Startups1 分钟阅读
标题为英语Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
TechCrunch — AI作者: Marina Temkin2026年9月23日 (9月23日)
提供 1 种语言版本AI 摘要:要点
- The round valued the AI biotech at $2 billion
- It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Startups
KZ·AI C80CИнсайт дня
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
标签:#Anthropic
相关文章
OpenAI 如何将其编码工具转变为 dots,一个始终在线的个人助手
负责 dots 的 OpenAI 高管 Alexander Embiricos 从不想与别人的 AI 代理开会。
TechCrunch — AI
ENIt's happening...
One of the most controversial companies in history just filed to go public. And yes, we're talking about Anthropic. The same company that says there's a greater than 10% chance AI kills all of humanity is also simultaneously one of the best built businesses of all time. And in…
YouTube — Matthew Berman
人为首次公开募股文件
配售数量及每股价格尚未公布
Kapital.kz
SMNTCN (Semanticon) — глобальные новости ИИ

